SWOG clinical trial number
S1918
A Phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed diffuse large B cell lymphoma, Grade IIIb Follicular Lymphoma, transformed lymphoma, and high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements
32% Accrual
Accrual
32%
Open
Phase
32% Accrual
Accrual
32%
Abbreviated Title
Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL
Status Notes
Activation - Effective 3/19/21, 12:00 pm Pacific Time
Training for Conduct of FIL Tool, accessible from: https://www.swog.org/required-s1918-training.
Online FIL Tool, accessible from: https://redcap.filinf.it/surveys/?s=RF4FPKH799.
Note: Responses must also be submitted in iMedidata RAVE, as indicated in protocol Section 14.5a, along with the score generated by the online FIL Tool.
Training for Conduct of FIL Tool, accessible from: https://www.swog.org/required-s1918-training.
Online FIL Tool, accessible from: https://redcap.filinf.it/surveys/?s=RF4FPKH799.
Note: Responses must also be submitted in iMedidata RAVE, as indicated in protocol Section 14.5a, along with the score generated by the online FIL Tool.
Activated
03/19/2021
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS LISTED ON TITLE PAGE
Research committees
Lymphoma
Treatment
Cyclophosphamide
Prednisone
Vincristine
Doxorubicin
Filgrastim
Rituximab
Pegfilgrastim
CC-486
CHOP
Other Study Materials
Eligibility Criteria Expand/Collapse
Publication Information Expand/Collapse
Other Clinical Trials
S2308
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
08/01/2024
13% Accrual
Accrual
13%
Open
Phase
S2207
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Activated
06/30/2023
12% Accrual
Accrual
12%
Open
Phase
CTSU/AHOD2131
SWOG Clinical Trial Number
Research Committee(s)
Lymphoma
Immunomolecular Therapeutics
Activated
04/28/2023
Open
Phase